Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ZL-1310 |
Synonyms | |
Therapy Description |
Limited information is currently available on ZL-1310, a putative DLL3 antibody-drug conjugate (ADC) (Jan 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ZL-1310 | ZL1310|ZL 1310 | Limited information is currently available on ZL-1310, a putative DLL3 antibody-drug conjugate (ADC) (Jan 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06179069 | Phase I | ZL-1310 | An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer | Recruiting | USA | 0 |